Levomoprolol HCl

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 125516

CAS#: 113482-87-4 (HCl)

Description: Levomoprolol is a beta adrenergic antagonist. It is the (S)-enantiomer of moprolol.

Chemical Structure

img
Levomoprolol HCl
CAS# 113482-87-4 (HCl)
Instruction

Theoretical Analysis

MedKoo Cat#: 125516
Name: Levomoprolol HCl
CAS#: 113482-87-4 (HCl)
Chemical Formula: C13H22ClNO3
Exact Mass: 275.13
Molecular Weight: 275.770
Elemental Analysis: C, 56.62; H, 8.04; Cl, 12.85; N, 5.08; O, 17.40

Price and Availability

This product is not in stock, which may be available by custom synthesis. For cost-effective reason, minimum order is 1g (price is usually high, lead time is 2~3 months, depending on the technical challenge). Quote less than 1g will not be provided. To request quote, please email to sales @medkoo.com or click below button.
Note: Price will be listed if it is available in the future.

Request quote for custom synthesis

Related CAS #: 113482-87-4 (HCl)   77164-20-6 (free base)  

Synonym: Levomoprolol hydrochloride; Levotensin hydrochloride; (S)-(-)-Moprolol hydrochloride; UNII-Y11ZSQ6XK4; Y11ZSQ6XK4

IUPAC/Chemical Name: (S)-1-(isopropylamino)-3-(2-methoxyphenoxy)propan-2-ol hydrochloride

InChi Key: JKEZSJIWQWVVQR-MERQFXBCSA-N

InChi Code: InChI=1S/C13H21NO3.ClH/c1-10(2)14-8-11(15)9-17-13-7-5-4-6-12(13)16-3;/h4-7,10-11,14-15H,8-9H2,1-3H3;1H/t11-;/m0./s1

SMILES Code: Cl.COC1=C(OC[C@@H](O)CNC(C)C)C=CC=C1

Appearance: To be determined

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 -4 C for short term (days to weeks) or -20 C for long term(months to years).

Solubility: To be determined

Shelf Life: >2 years if stored properly

Drug Formulation: To be determined

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

More Info:

Biological target:
In vitro activity:
In vivo activity:

Preparing Stock Solutions

The following data is based on the product molecular weight 275.77 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol:
In vitro protocol:
In vivo protocol:

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

1: Ghosh S, Bhaumik J, Banoth L, Banesh S, Banerjee UC. Chemoenzymatic Route for the Synthesis of (S)-Moprolol, a Potential β-Blocker. Chirality. 2016 Apr;28(4):313-8. doi: 10.1002/chir.22574. Epub 2016 Jan 28. PubMed PMID: 26821612.

2: Gianesello V, Brenn E, Figini G, Gazzaniga A. Determination by coupled high-performance liquid chromatography-gas chromatography of the beta-blocker levomoprolol in plasma following ophthalmic administration. J Chromatogr. 1989 Jul 7;473(2):343-52. PubMed PMID: 2570078.

3: Pecori-Giraldi J, Virno M, Ciarnella A, Taverniti L. [The beta-blocker levomoprolol in the treatment of glaucoma]. Bull Mem Soc Fr Ophtalmol. 1985;96:433-6. French. PubMed PMID: 2861871.

4: Santambrogio R, Opocher E, Galeotti F, Montorsi M, Cucchiaro G, Gagliano G, Spina GP. [The hemodynamic effects on the portal system of levomoprolol and propranolol in rats with an enhanced adrenergic tonus]. Minerva Med. 1989 Aug;80(8):949-51. Italian. PubMed PMID: 2571957.

5: Lai C, Tallu B, Onnis E, Pirisi R, Cioglia G, Cherchi A. [Effects of acute administration of the levogyral beta-blocker levomoprolol on the exercise test in angina pectoris]. Cardiologia. 1984 Dec;29(12):605-14. Italian. PubMed PMID: 6152549.

6: Pecori-Giraldi J, Virno M, Ralli R, Planner-Terzaghi A. [Long-term treatment of wide-angle glaucoma with the beta blocker levomoprolol: therapeutic effectiveness without side effects]. Fortschr Ophthalmol. 1986;83(5):564-6. German. PubMed PMID: 2878862.

7: Rossetti L, Barbieri P, Velati P, Bujtar E, Orzalesi N. The efficacy of the combination of l-moprolol and dipivefrin in reducing the intraocular pressure in primary open-angle glaucoma or in ocular hypertension. Graefes Arch Clin Exp Ophthalmol. 1994 Nov;232(11):670-4. PubMed PMID: 7843592.

8: Alinovi A, Branchetti A, Barella PA. [Iatrogenic dermatoses caused by beta-blocking drugs]. G Ital Dermatol Venereol. 1983 Nov-Dec;118(6):341-8. Review. Italian. PubMed PMID: 6143722.

9: Duclos J, Kussaibi H, Pacault V, Roussel H, Sandid W, Janin A, Bertheau P. [A case of giant cell microscopic colitis?]. Ann Pathol. 2008 Dec;28(6):501-3. doi: 10.1016/j.annpat.2008.09.045. Epub 2008 Nov 17. French. PubMed PMID: 19084720.

10: White JD, Shaw S. A new catalyst for the asymmetric Henry reaction: synthesis of β-nitroethanols in high enantiomeric excess. Org Lett. 2012 Dec 21;14(24):6270-3. doi: 10.1021/ol3030023. Epub 2012 Nov 30. PubMed PMID: 23194499.

11: Harvengt C, Desager JP. The pharmacokinetics of dl- and l-moprolol in the human. Int J Clin Pharmacol Ther Toxicol. 1982 Feb;20(2):57-61. PubMed PMID: 6120901.

12: Triulzi MO, Balice G, Gentile F, Rossini GL, Fattori CM. Tolerability of high doses of (-)-moprolol in healthy volunteers. Eur J Clin Pharmacol. 1982;22(4):377-8. PubMed PMID: 6125397.

13: Ghirardi P, Grosso F. Antihypertensive activity of (-) moprolol in man: double-blind comparison of enantiomers. J Cardiovasc Pharmacol. 1980 Jul-Aug;2(4):471-2. PubMed PMID: 6156344.

14: Merlo L, Brusoni B, Mussini E, Ghirardi P. [The cardiovascular effects of the optical isomers of 1-(0-methoxy-phenoxy-)-3-isopropylamino-2-propanolo-hydrochloride (moprolol)]. Boll Soc Ital Cardiol. 1980;25(8):955-61. Italian. PubMed PMID: 6116496.

15: el-Ashmawy MB, Lissavetzky J, Darias V, Martín-Herrera D. Synthesis and pharmacological study of a thiophene analogue of moprolol and related compounds. Arch Pharm (Weinheim). 1991 Jan;324(1):45-8. PubMed PMID: 1675047.

16: Li F, Bi H, Côté M, Cooper S. Identification and determination of the enantiomers of moprolol and their metabolites in human urine by high-performance liquid chromatography and gas chromatography-mass spectrometry. J Chromatogr. 1993 Dec 22;622(2):187-95. PubMed PMID: 7908669.

17: Porciatti F, Cerbai E, Masini I, Mugelli A. Electrophysiological evaluation of the beta-blocking properties and direct membrane effects of l-moprolol and its enantiomer d-moprolol. Arch Int Pharmacodyn Ther. 1989 May-Jun;299:200-9. PubMed PMID: 2570555.

18: Santambrogio R, Galeotti F, Opocher E, Cucchiaro G, Cornalba GP, Rota L, Ferrario M, Fumagalli U, Spina GP. [Role of beta blockers in preventing hemorrhages from esophageal varices. A hemodynamic study]. Minerva Med. 1986 Mar 24;77(12):429-32. Italian. PubMed PMID: 2871526.

19: De Ambroggi L, Perotta GM, Satolli R, Lotto A. [Evaluation of the effects of a beta-blocking drug (moprolol) on hemodynamics and lesion potentials in acute myocardial infarct]. Boll Soc Ital Cardiol. 1977;22(8):1343-51. Italian. PubMed PMID: 36116.